CSI Market
Sign In | Register

Heron Therapeutics Inc (HRTX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access HRTX Annual Balance Sheets →
From Heron Therapeutics Inc through Sep 30 2025, shifts in Sep 30 2026's assets and liabilities provide insight into the company's capital structure and financial stability.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/HRTX/balance-sheets
https://api.csimarket.com/api/v1/companies/HRTX/fundamentals
https://api.csimarket.com/api/v1/companies/HRTX/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & cash equivalent11.60
Available-for-sale Securities, Debt Securities, Current MA11.85
Cash & Short-term Investments22.00
Accounts receivable86.74
Inventories91.30
Other Current Assets0.00
Prepaid Expense And Other Assets Current7.63
Total Current Assets209.11
Equipment/Property/Plant Net11.08
Other Assets, Noncurrent10.26
Operating Lease Right Of Use Asset-
Total Assets230.45
Liabilities
Accounts Payable, Current AC8.38
Employee-related Liabilities, Current AC8.84
Other Liabilities, Current72.64
Total Current Liabilities89.85
Convertible Notes Payable, Noncurrent LO34.38
Total Long-term Debt34.38
Other liabilities, Noncurrent101.31
Accrued Clinical Liabilities25.17
Operating Lease Liability Current-
Non Current Notes Payable Excluding Convertible Notes Payable-
Total Liabilities225.53
Stockholders' Equity
Common Stock Value1.90
Additional Paid In Capital Common Stock1,960.37
Retained Earnings / Accumulated Deficit-1,958.40
Accumulated Other Comprehensive Income-0.01
Other Equity-0.01
Common Stockholder's Equity3.87
Preferred Stockholder's Equity1.05
Total Stockholder's Equity4.92
Liabilities & Stockholder's Equity230.45
4 historic quarters locked

Sign in to unlock the full Heron Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Heron Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-452759

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI